About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Alzheimer's Polygenic Risk Score can Identify Adults with Cognitive Impairment

by Preethi Sivaswaamy Mohana on March 6, 2018 at 12:18 PM
Font : A-A+

Alzheimer's Polygenic Risk Score can Identify Adults with Cognitive Impairment

Mild cognitive impairment (MCI), precursor to Alzheimer's disease (AD) in adults who are only 50 can be identified with polygenic risk score, according to a study led by a research team at University of California San Diego School of Medicine. The findings of the study are published in the journal Molecular Psychiatry .

The AD polygenic risk score was created from genome-wide association studies of AD with a combination of genes weighted according to the association of single nucleotide polymorphisms (SNPs) with AD. SNPs are variations of a single nucleotide or DNA-building block that occur at a specific position in the genome. There is some SNP variation in genomic information in all humans, which affects individual susceptibility to disease.

Advertisement


"Current studies of the AD polygenic risk score typically occur in adults in their 70s, but the AD pathological process begins decades before the onset of dementia," said William S. Kremen, PhD, professor of psychiatry and co-director of the Center for Behavior Genetics of Aging at UC San Diego School of Medicine. "By focusing on a younger population with cognitive impairment, we may be better able to identify patients for critical early interventions and clinical trials."

Kremen and team found that someone with an AD polygenic risk score in the upper quartile was 2.5 to 3 times more likely to have MCI than someone with a score in the lowest quartile. Signs of MCI may include difficulty with word recall, forgetting appointments, or often losing personal belongings. The type of MCI most associated with memory loss is called amnestic MCI.
Advertisement

According to the National Institute on Aging, more people with MCI than those without it go on to develop Alzheimer's. Approximately eight of every 10 persons who fit the definition of amnestic MCI develop Alzheimer's disease within seven years.

"Our research team found that the polygenic score could differentiate individuals with mild cognitive impairment from those who were cognitively normal," said Kremen. "We also noticed that for study participants who had cognitive deficits other than memory problems, diabetes was three-fold more likely."

Kremen added that while this test is not yet available to primary care physicians, it may be an important tool to aid researchers in predicting MCI and AD, and, eventually, reducing the number of future cases.

"The Alzheimer's Association and others have modeled how the impact of delaying the onset of AD by five years could reduce the number of cases by nearly 50 percent by 2050. We want to do what we can to make this projection a reality," said Kremen.

Data for this study were collected from 1,329 men who participated in the Vietnam Era Twin Study of Aging (VESTA.). VESTA constitutes a national sample comparable to U.S. men in their age range with respect to health and lifestyle characteristics. Approximately 90 percent of subjects in this analysis were in their 50s. Diagnosis of AD was based on the Jak-Bondi actuarial/neuropsychological approach.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Health Benefits of Sea Buckthorn
Contraceptive Pills in Polycystic Ovary Syndrome (PCOS) Curtail Type 2 Diabetes Risk
Mushroom May Help Cut Down the Odds of Developing Depression
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.


Recommended Reading
Alzheimers Disease
Alzheimer's disease is a progressive neurodegenerative disease affecting memory and thinking and ......
Speaking Two Languages may Benefit Alzheimer's Patients
Speaking more than one language can help maintain memory reserve in patients with Alzheimer's ......
Alzheimer's Disease Can't be Cured, But Treatment May Help
No medications and strategies have surfaced strongly which can cure Alzheimer's but researchers ......
Stem-cell Study Creates New Advancement Towards Alzheimer’s Disease
An experimental compound found to reduce the amount of toxic cells that is present in the brain ......

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use